Synapse - Zebing Liu

Zebing Liu

Research Focus

Former Employee. SKI Clinical Lab Services; Research Fellow

Recent additions – View all

Combination of MDM2 and targeted kinase inhibitors results in prolonged tumor control in lung adenocarcinomas with oncogenic tyrosine kinase drivers and MDM2 amplification
Journal Article

Elkrief, A.; Odintsov, I.; Smith, R. S.; Vojnic, M.; Hayashi, T.; Khodos, I.; Markov, V.; Liu, Z.; Lui, A. J. W.; Bloom, J. L.; more...
JCO Precision Oncology (2024)

Fulltext@MSK | Save
Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling
Journal Article

Smith, R. S.; Odintsov, I.; Liu, Z.; Lui, A. J. W.; Hayashi, T.; Vojnic, M.; Suehara, Y.; Delasos, L.; Mattar, M. S.; Hmeljak, J.; more...
Disease Models & Mechanisms (2022)

Fulltext@MSK | Save
RET inhibition in novel patient-derived models of RET fusion-positive lung adenocarcinoma reveals a role for MYC upregulation
Journal Article

Hayashi, T.; Odintsov, I.; Smith, R. S.; Ishizawa, K.; Liu, A. J. W.; Delasos, L.; Kurzatkowski, C.; Tai, H.; Gladstone, E.; Vojnic, M.; more...
Disease Models & Mechanisms (2021)

Fulltext@MSK | Save

Co-authors at MSK

Types of Work

Publications